Filter
2052
Filtered Results: 2052
Text search:
Drug
Safety
Monitoring
Programme
Featured
Recommendations
228
New Publications
668
Language
Document type
No document type
1250
Guidelines
299
Studies & Reports
245
Manuals
112
Strategic & Response Plan
92
Training Material
21
Fact sheets
18
Situation Updates
8
Infographics
4
Resource Platforms
2
Online Courses
1
Countries / Regions
India
131
Kenya
72
Global
59
South Africa
57
Nigeria
55
Uganda
50
Sierra Leone
44
Tanzania
41
Western and Central Europe
41
Nepal
39
Ghana
38
Ethiopia
35
Zambia
35
Myanmar / Burma
35
Liberia
30
Malawi
30
Bangladesh
28
Africa
28
Namibia
27
Eastern Europe
18
South–East Asia Region
17
Lesotho
16
Zimbabwe
14
Cambodia
14
Botswana
13
Latin America and the Carribbean
13
Asia
13
Rwanda
12
Philippines
11
Syria
11
Indonesia
10
Ukraine
10
Congo, Democratic Republic of
9
Russia
8
Cameroon
7
Eswatini/ Swaziland
7
Senegal
6
Pakistan
6
East and Southern Africa
6
West and Central Africa
6
Eastern Europe and Central Asia
6
Tajikistan
6
Burkina Faso
5
South Sudan
5
Thailand
5
Middle East and North Africa
5
Western Pacific Region
5
Albania
5
Mozambique
4
Laos
4
Guinea
3
Iraq
3
Germany
3
Georgia
3
USA
2
Haiti
2
Somalia
2
Afghanistan
2
China
2
Sudan
2
Brazil
2
Sri Lanka
2
Bhutan
2
United Kingdom
2
Jordan
1
Lebanon
1
Turkey
1
Gambia
1
Ireland
1
Singapore
1
Benin
1
Central African Republic
1
Peru
1
North Macedonia
1
Serbia
1
Colombia
1
Honduras
1
El Salvador
1
Libya
1
Angola
1
Madagascar
1
Yemen
1
Paraguay
1
Poland
1
Southern Africa
1
Canada
1
Timor Leste/ East Timor
1
Qatar
1
Bulgaria
1
Lithuania
1
Moldova
1
Uzbekistan
1
Kyrgyzstan
1
Vietnam
1
North America
1
Gabon
1
Turkmenistan
1
Denmark
1
Maldives
1
Mauritius
1
Authors & Publishers
Publication Years
Category
Countries
838
Clinical Guidelines
214
Public Health
135
Women & Child Health
94
Key Resources
69
Pharmacy & Technologies
36
Capacity Building
28
Toolboxes
HIV
234
TB
173
AMR
145
Mental Health
127
Pharmacy
74
COVID-19
73
Caregiver
49
Rapid Response
47
NTDs
45
NCDs
41
Ebola
34
Planetary Health
32
Conflict
27
Global Health Education
26
Disability
22
Refugee
21
Cholera
9
Polio
9
Natural Hazards
9
Health Financing Toolbox
9
Specific Hazards
8
Zika
5
This document is based on currently available scientific evidence on treatment for drug use disorders and sets out a framework for the implementation of the Standards, in line with principles of public health care. The Standards identify major compo...
Over the past twenty years, huge efforts made by a broad coalition of stakeholders curbed the last epidemic and brought the disease to the brink of elimination. In this paper, the latest figures on disease occurrence, geographical distribution and control activities are presented. Strong evidence in...
2nd. edition
The new edition has been developed to make widely available to programme managers, health care workers in endemic settings, academic researchers, and other key partners, a concise source of information on strategies for MMDP for LF. It...
Lymphatic filariasis: managing morbidity and preventing disability: an aide-mémoire for national programme managers, second edition: web annex A: protocol for evaluating minimum package of care of morbidity management and disability prevention for ...
The emergence of multifrug-resistant malaria in the Greater Mekong Subregion (GMS) has been identified as an emergency issue that may have catastrophic consequences on the future of malaria elimination in the GMS as well as globally. In recognition of the need for a cohesive regional response,...
2020 is a critical year for our Joint Programme as we collectively define the path to getting back on track to ending the AIDS epidemic by 2030. Our revised timelines for adoption of the next strategy are highly ambitious. We need the full support o...
These guidelines group all recommendations on TB care and support in one document and are complemented by an operational handbook. The guidelines are to be used primarily by national TB programmes, or their equivalents in Ministries of Health, ...
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of...
Effective malaria case management requires quick access to diagnostics and antimalarial treatments to reduce illness and death. Artemisinin-based combination therapy (ACT) has been essential to malaria treatment since 2001, as it combines artemisinin for rapid parasite reduction with a partner ... to ensure complete cure. However, resistance to antimalarial drugs, where parasites survive standard doses, threatens malaria control.
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of...
Meeting Report 27-29 October 2020
The overall goal of the meeting was to discuss recent changes in treatment regimens and diagnostics for drug-resistant TB and to determine how these impact on the definition of XDR-TB, with a view to revising this ...
